Switzerland· 66190001
Vemlidy, Filmtabletten
A nucleoside and nucleotide reverse transcriptase inhibitors product containing tenofovirum alafenamidum, registered in Switzerland by Gilead Sciences Switzerland Sàrl and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Tenofovirum alafenamidum is registered in 2 of 19 countries.
Countries holding a registration under ATC J05AF (nucleoside and nucleotide reverse transcriptase inhibitors), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 2 of them publish a price we can compare per daily dose
Tenofovirum alafenamidum · ATC J05AF
2 / 19 countries
- Switzerlandprice
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- tenofovirum alafenamidum
- Manufacturer
- Gilead Sciences Switzerland Sàrl
- Country
- Switzerland (CH)
- ATC code
- J05AF
- ATC class
- Nucleoside and nucleotide reverse transcriptase inhibitors
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680661900012Fl 30 StkCHF 504.85
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tenofovirum alafenamidum in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandVemlidy2care4 ApS
- NorwayVemlidyGilead Sciences Ireland UC
- CzechiaVEMLIDYGilead Sciences Ireland UC, Carrigtohill
- IcelandVemlidyGilead Sciences Ireland UC*
- NetherlandsTenofoviralafenamide Devatis 25 mg, filmomhulde tablettenDevatis GmbH
- PolandVemlidyGilead Sciences Ireland UC
- BelgiumVemlidy 25 mgGilead Sciences Ireland UC
- SwedenVemlidy 25 mg Filmdragerad tablettGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Germany · Tenofoviralafenamid Devatis
- Iceland · Vemlidy
- Liechtenstein · Vemlidy
- Netherlands · Tenofoviralafenamide Devatis
- Norway · Vemlidy
- Portugal · Tenofovir Alafenamida Humanis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa9873d4-45c5-4fb2-b0fe-d8cec0511d1a GET /v1/drugs/fa9873d4-45c5-4fb2-b0fe-d8cec0511d1a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "tenofovirum alafenamidum 25 mg",
"valid_from": "2017-08-01",
"limitations": null,
"galenic_form": "Filmtabl 25 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2017-08-01",
"self_retention_pct": 10
}See everything about tenofovirum alafenamidum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.